Streetbeat News

Price Targets

MCK

McKesson's stock is trading lower following a downgrade by Baird from Outperform to Neutral, with a reduced price target from $603 to $531.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:52 pm

BNTX

BioNTech shares rise as Morgan Stanley upgrades the stock from Equal-Weight to Overweight, increasing the price target from $93 to $145.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:49 pm

REGN

Truist Securities has reiterated its Buy rating for Regeneron Pharmaceuticals, maintaining a price target of $1200.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:49 pm

CEG

Barclays analyst Nicholas Campanella maintains an Overweight rating on Constellation Energy and raises the price target from $211 to $280.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:47 pm

ZVRA

Zevra Therapeutics shares rose after announcing positive Phase 2 trial results for KP1077 in idiopathic hypersomnia. Maxim Group and Roth MKM raised price targets, and JMP Securities initiated coverage with a Market Outperform rating.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:45 pm

NTR

Wells Fargo has downgraded Nutrien (NYSE:NTR) from Overweight to Equal-Weight and reduced its price target from $62 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:41 pm

FBLG

FibreBiologics shares rose following Maxim Group's initiation of coverage with a Buy rating and a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:38 pm

BRZE

Braze shares declined after Oppenheimer reduced its price target from $60 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:36 pm

COST

Truist Securities has downgraded Costco Wholesale from Buy to Hold, while maintaining the price target at $873.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:33 pm

CFLT

JMP Securities analyst Patrick Walravens has reiterated a Market Outperform rating for Confluent (NASDAQ:CFLT) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:32 pm